We (the ASCO delegation) have just returned from the interim American Medical Association (AMA) House of Delegates meeting in Orlando. ASCO proposed a resolution focused on the restrictive opioid policies...

Vice President Joe Biden and the government-wide Cancer Moonshot Task Force have presented today a sweeping vision that, if realized, could change the face of cancer prevention, screening, treatment, and...

Many of the successful, FDA-approved drugs commonly used in cancer care were developed at small biotech or pharma companies—so what role do the "big fish" play?

Believe it or not, the Medicare Access and CHIP Reauthorization Act of 2015 was passed more than 1 year ago, and program changes begin in less than six months, on Janurary 1, 2017.